ID Source | ID |
---|---|
PubMed CID | 81401 |
SCHEMBL ID | 5930961 |
MeSH ID | M0096594 |
Synonym |
---|
4-13-00-01023 (beilstein handbook reference) |
6954-41-2 |
nsc-37166 |
nsc37166 |
nsc 37166 |
desacetyldiamfenetide |
bis(beta-(4-aminophenoxy)ethyl)ether |
beta,beta-bis(4-aminophenyloxy)ethyl ether |
m and b 2540 |
4,4'-oxybis(2,1-ethanediyloxy)bisbenzenamine |
4,4'-(oxybis(ethyleneoxy))dianiline |
benzenamine, 4,4'-oxybis(2,1-ethanediyloxy)bis- |
bis(beta-(4-aminophenoxy)ethyl) ether |
einecs 230-137-3 |
brn 0421240 |
diamphenethide-amine |
4-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]aniline |
benzenamine,4,4'-[oxybis(2,1-ethanediyloxy)]bis- |
SCHEMBL5930961 |
DTXSID80219799 |
SR-01000212369-1 |
sr-01000212369 |
bis[2-(4-aminophenoxy)ethyl]ether |
UV7FQ27K5Z |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.53) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |